Masahiro Shiokawa
Overview
Explore the profile of Masahiro Shiokawa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
72
Citations
754
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yamamoto S, Kuwada T, Shiokawa M, Kitamoto H, Okabe M, Seno H
Gastro Hep Adv
. 2025 Feb;
4(3):100582.
PMID: 39926205
No abstract available.
2.
Okada H, Uza N, Matsumori T, Yamazaki H, Yasuda M, Kuwada T, et al.
Gut Liver
. 2025 Jan;
19(1):136-144.
PMID: 39778881
Background/aims: Pathological evaluation is crucial for diagnosing biliary lesions and determining appropriate treatment strategies. However, tissue sampling via the transpapillary route can be difficult. In this study, we aimed to...
3.
Okabe M, Yamamoto S, Shiokawa M, Hisamatsu T, Yamazaki H, Nakanishi R, et al.
J Gastroenterol
. 2024 Dec;
60(2):263-264.
PMID: 39729094
No abstract available.
4.
Yokode M, Shiokawa M, Kodama Y
Nihon Shokakibyo Gakkai Zasshi
. 2024 Dec;
121(12):957-963.
PMID: 39662923
No abstract available.
5.
Nakanishi R, Kuwada T, Shiokawa M, Nishikawa Y, Ota S, Yamazaki H, et al.
Inflamm Bowel Dis
. 2024 Dec;
31(3):777-785.
PMID: 39657162
Background: Pouchitis is the most common complication of restorative proctocolectomy (RPC) with ileal pouch-anal anastomosis (IPAA) in patients with ulcerative colitis (UC). We previously reported the presence of anti-integrin αvβ6...
6.
Okabe M, Yamamoto S, Shiokawa M, Hisamatsu T, Yamazaki H, Nakanishi R, et al.
J Gastroenterol
. 2024 Nov;
60(1):86-95.
PMID: 39607498
Background: A serum biomarker for diagnosing ulcerative colitis (UC) remains to be established. Although we recently reported an anti-integrin αvβ6 antibody (V6 Ab) for diagnosing UC with high sensitivity and...
7.
Yasuda M, Shiokawa M, Kuwada T, Nishikawa Y, Nakanishi R, Takimoto I, et al.
J Gastroenterol
. 2024 Nov;
60(1):118-126.
PMID: 39549066
Background: Although specific biomarkers for primary sclerosing cholangitis (PSC) are required, no such biomarkers have been identified. We previously reported that patients with PSC had anti-integrin αvβ6 autoantibodies at only...
8.
Yaku H, Takahashi K, Okada H, Kobiyama K, Shiokawa M, Uza N, et al.
Biochem Biophys Res Commun
. 2024 Aug;
737:150534.
PMID: 39142137
Pancreatic cancer is one of the most refractory malignancies. In situ vaccines (ISV), in which intratumorally injected immunostimulatory adjuvants activate innate immunity at the tumor site, utilize tumor-derived patient-specific antigens,...
9.
Hirata A, Matsumori T, Yasuda M, Nishikawa Y, Shiokawa M, Uza N, et al.
Clin J Gastroenterol
. 2024 Jun;
17(5):982-988.
PMID: 38902593
Acute obstructive suppurative pancreatic ductitis (AOSPD) is an acute suppuration of the pancreatic duct. Endoscopic retrograde cholangiopancreatography (ERCP) drainage and intravenous antibiotics treatment is the mainstay of therapy. Herein we...
10.
Ito T, Takeuchi Y, Mizuno K, Imai M, Yoshimaru Y, Abe K, et al.
Hepatol Res
. 2024 Jun;
54(8):719-726.
PMID: 38884591
With the widespread use of immune checkpoint inhibitors (ICIs), liver injury (ICI-induced liver injury) as an immune-related adverse event has become a major concern in clinical practice. Because severe cases...